Screening and treatment of diabetic retinopathy by the Brazilian National Health Insurance
Saidi, P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Practice. 157107843 (2019).
American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetic treatments 44S15–S33 (2021).
Lovic, D. et al. The growing epidemic of diabetes mellitus. Running. Vasc. Pharmacol. 18104-109 (2020).
Khalil, H. Microvascular Complications of Diabetes – A Clinical Update. Diabetes Metab. syndr. 11S133–S139 (2017).
GBD. Collaborators for blindness and visual impairment. Causes of blindness and visual impairment in 2020 and 30-year trends, and prevalence of avoidable blindness compared to VISION 2020: The Right to Sight: An Analysis for the Global Burden of Disease Study. Lancet Glob. Health 9e144–e160 (2019).
Wong, Ty et al. Diabetic eye care guidelines: International Council of Ophthalmology recommendations for screening, follow-up, referral and resource-based treatment. Ophthalmology 1251608-1622 (2018).
Teo, ZL et al. Global prevalence of diabetic retinopathy and projected burden to 2045: systematic review and meta-analysis. Ophthalmology 281580-1591 (2021).
Ferris, FL How effective are treatments for diabetic retinopathy?. JAMA 2691290-1291 (1993).
Cheung, N., Mitchell, P., and Wong, TY Diabetic retinopathy. Lancet 376124-136 (2010).
El Rami, H., Barham, R., Sun, JK & Silva, PS Evidence-based treatment of diabetic retinopathy. Semin Ophthalmol. 3267-74 (2017).
Bittencourt, SA, Camacho, LAB & Leal, MC Hospital information systems and their application in public health. Cad Saude Publica 2219-30 (2006).
Paim, J., Travassos, C., Almeida, C., Bahia, L. & Macinko, J. The Brazilian health system: history, progress and challenges. Lancet 3771778–1797 (2011).
Viacava, F. & Bellido, JG Santé, access to services and sources of payment, according to household surveys. Cien Saude Colet. 21351–370 (2016).
Massuda, A., Hone, T., Leles, FAG, de Castro, MC & Atun, R. The Brazilian health system at a crossroads: Progress, crisis and resilience. BMJ Global Health 3e000829 (2018).
Silva, B. et al. Dual use of public and private health services in Brazil. Int J. About. Res. Public health 191829 (2022).
Malerbi, CF et al. Retinal examinations ordered at the primary care unit: indications, results and alternative evaluation strategies. Einstein Sao Paulo 18eGS4913 (2020).
Gastner, MT, Seguy, V. & More, P. Fast flow-based algorithm for creating density equalization map projections. proc. Natl. Acad. Sci. UNITED STATES 115E2156–E2164 (2018).
Monteiro, California et al. Monitoramento de fatores de risco para doenças crônicas por entrevistas telefônicas [Surveillance of risk factors for chronic diseases through telephone interviews]. Reverend Saude Publica 3947–57 (2005).
Vujosevic, S. et al. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 8337–347 (2020).
Mumba, M., Hall, A. & Lewallen, S. Compliance with eye screening examinations in diabetic patients at a Tanzanian referral hospital. Ophthalmic epidemiol. 14306-310 (2007).
Moreton, RBR, Stratton, IM, Chave, SJ, Lipinski, H. & Scanlon, PH Factors determining uptake of diabetic retinopathy screening in Oxfordshire. Diabetes med. 34993–999 (2017).
Meyer, RE and Herrick, H. Prevalence of diabetes-related eye disease in North Carolina: results from the North Carolina Behavioral Risk Factor Surveillance System. NC Med. J 72413–416 (2011).
Mukamel, DB, Bresnick, GH, Wang, Q. & Dickey, CF Barriers to meeting diabetic retinopathy screening guidelines. Ophthalmic epidemiol. 661–72 (1999).
Jones, S. & Edwards, RT Screening for diabetic retinopathy: a systematic review of the economic evidence. Diabetes med. 27249-256 (2010).
Avidor, D., Loewenstein, A., Waisbourd, M. & Nutman, A. Cost-effectiveness of telemedicine diabetic retinopathy screening programs: a systematic review. Cost Eff. Resour. Allowance 1816 (2020).
Tan, CH, Kyaw, BM, Smith, H., Tan, CS, and Tudor Car, L. Using smartphones to detect diabetic retinopathy: a scoping review and meta-analysis of diagnostic test accuracy studies. J.Med. Internet res. 22e16658 (2020).
Gupta, A., Cavallerano, J., Sun, JK & Silva, PS Evidence of telemedicine for diabetic retinal disease. Semin. Ophthalmol. 3222–28 (2017).
Huemer, J., Wagner, SK & Sim, DA The evolution of diabetic retinopathy screening programs: a timeline of retinal photography from 35mm slides to artificial intelligence. Clin. Ophthalmol. 142021-2035 (2020).
Kalogeropoulos, D., Kalogeropoulos, C., Stefaniotou, M. & Neofytou, M. The role of tele-ophthalmology in diabetic retinopathy screening. J.Optom. 13262-268 (2020).
Scanlon, PH Screening intervals for diabetic retinopathy and implications for care. Running. Diabetes representative 1796 (2017).
Scanlon, PH et al. Development of a cost-effectiveness model for the optimization of the screening interval in the screening of diabetic retinopathy. Technology. Health Assess. 191–116 (2015).
Leese, general practitioner et al. Progression of diabetes retinal status in community screening programs and potential implications for screening intervals. Diabetic treatments 38488–494 (2015).
Taylor-Phillips, S. et al. Extending the screening interval for diabetic retinopathy beyond one year: a systematic review. Br. J. Ophthalmol. 100105-114 (2016).
Scanlon, PH The English national screening program for sight-threatening diabetic retinopathy. J.Med. Filter. 151–4 (2008).
Agardh, E. & Tababat-Khani, P. Adoption of 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetic treatments 341318-1319 (2011).
Jones, CD, Greenwood, RH, Misra, A. & Bachmann, MO Incidence and progression of diabetic retinopathy over 17 years of a population-based screening program in England. Diabetic treatments 35592-596 (2012).
Looker, HC et al. Predicted impact of lengthening the diabetic retinopathy screening interval: the Scottish Diabetic Retinopathy Screening Scheme. Diabetology 561716-1725 (2013).
Khandekar, R., Al Lawatii, J., Mohammed, AJ, and Al Raisi, A. Diabetic retinopathy in Oman: a hospital-based study. Br. J. Ophthalmol. 871061-1064 (2003).
Quille, S. et al. The prevalence of diabetic retinopathy in Australian adults with self-reported diabetes: the National Eye Health Survey. Ophthalmology 124977–984 (2017).
Okonkwo, ON et al. Indications and results of vitrectomy surgery in a series of 1000 black African eyes. Ophthalmol open BMJ. 4e000083 (2019).
Conselho Brasileiro de Oftalmologia. As condições de saúde ocular no Brasil. (2019). Available at: https://www.cbo.com.br/novo/publicacoes/condicoes_saude_ocular_brasil2019.pdf Accessed November 28, 2021.
Nascimento, LG et al. A new Brazilian regional scenario of type 2 diabetes risk in the next ten years. Prime. Diabetes care 151019-1025 (2021).